ATE226430T1 - Verfahren zur herstellung hydro-monobenzoporhyrin photosensibilisatoren enthaltender liposomen - Google Patents

Verfahren zur herstellung hydro-monobenzoporhyrin photosensibilisatoren enthaltender liposomen

Info

Publication number
ATE226430T1
ATE226430T1 AT96925614T AT96925614T ATE226430T1 AT E226430 T1 ATE226430 T1 AT E226430T1 AT 96925614 T AT96925614 T AT 96925614T AT 96925614 T AT96925614 T AT 96925614T AT E226430 T1 ATE226430 T1 AT E226430T1
Authority
AT
Austria
Prior art keywords
photosensitizers
monobenzoporhyrin
liposomes containing
producing liposomes
containing hydro
Prior art date
Application number
AT96925614T
Other languages
English (en)
Inventor
Liu Ron
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE226430T1 publication Critical patent/ATE226430T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96925614T 1995-08-02 1996-07-29 Verfahren zur herstellung hydro-monobenzoporhyrin photosensibilisatoren enthaltender liposomen ATE226430T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/510,573 US5707608A (en) 1995-08-02 1995-08-02 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
PCT/CA1996/000512 WO1997004746A1 (en) 1995-08-02 1996-07-29 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers

Publications (1)

Publication Number Publication Date
ATE226430T1 true ATE226430T1 (de) 2002-11-15

Family

ID=24031289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96925614T ATE226430T1 (de) 1995-08-02 1996-07-29 Verfahren zur herstellung hydro-monobenzoporhyrin photosensibilisatoren enthaltender liposomen

Country Status (12)

Country Link
US (1) US5707608A (de)
EP (1) EP0843547B1 (de)
JP (1) JP3782112B2 (de)
AT (1) ATE226430T1 (de)
AU (1) AU717181B2 (de)
CA (1) CA2227761C (de)
DE (1) DE69624485T2 (de)
DK (1) DK0843547T3 (de)
ES (1) ES2186792T3 (de)
PT (1) PT843547E (de)
TW (1) TW585785B (de)
WO (1) WO1997004746A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69215722T3 (de) * 1991-03-22 2001-03-08 Katsuro Tachibana Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6143287A (en) * 1996-02-27 2000-11-07 New York Blood Center, Inc. Method and composition for hair removal
CA2202103C (en) 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
US6582392B1 (en) * 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
WO1999013916A2 (en) * 1997-09-18 1999-03-25 Nycomed Imaging As Methods and compositions for medical imaging
US6183727B1 (en) 1998-05-19 2001-02-06 Arizona Board Of Regents Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
US6608050B2 (en) * 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
CA2714081C (en) 2000-02-10 2013-08-06 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
AU5040101A (en) * 2000-03-24 2001-10-15 Novartis Ag Improved treatment of neovascularization
US8106038B2 (en) 2001-02-15 2012-01-31 Qlt Inc. Method for reducing or preventing PDT related inflammation
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
AU2007202603B2 (en) * 2001-04-11 2010-06-10 Valeant Pharmaceuticals International, Inc. Drug delivery system for hydrophobic drugs
ES2306785T3 (es) * 2001-11-02 2008-11-16 The Governors Of The University Of Alberta Composiciones de micelas que contienen fosfolipidos pegilados y un fotosensibilizador.
EP1453425B1 (de) 2001-12-03 2006-03-08 Ekos Corporation Katheter mit mehreren ultraschall-abstrahlenden teilen
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US7455858B2 (en) * 2002-05-16 2008-11-25 Qlt Inc. Compositions and methods for delivery of photosensitive drugs
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US7682603B2 (en) * 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US7341569B2 (en) * 2004-01-30 2008-03-11 Ekos Corporation Treatment of vascular occlusions using ultrasonic energy and microbubbles
US7419666B1 (en) 2004-02-23 2008-09-02 Massachusetts Eye And Ear Infirmary Treatment of ocular disorders
CA2604380A1 (en) * 2005-04-12 2006-10-19 Ekos Corporation Ultrasound catheter with cavitation promoting surface
EP2015846A2 (de) 2006-04-24 2009-01-21 Ekos Corporation Ultraschalltherapiesystem
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
JP5515075B2 (ja) * 2007-01-18 2014-06-11 国立大学法人 千葉大学 微粒子製剤
US9044568B2 (en) 2007-06-22 2015-06-02 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
EP2231024A4 (de) * 2007-12-14 2015-03-18 Ekos Corp Ultraschallpulsformung
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
WO2016161428A1 (en) * 2015-04-02 2016-10-06 The Research Foundation For The State University Of New York Serum-stable compositions and methods for light-triggered release of materials
WO2016201136A1 (en) 2015-06-10 2016-12-15 Ekos Corporation Ultrasound catheter
CN109843378B (zh) 2016-05-26 2022-06-10 匹兹堡大学联邦高等教育系统 用于治疗肺血管疾病的组合物和方法
KR102035384B1 (ko) * 2017-06-26 2019-10-22 서강대학교산학협력단 광감작제를 포함한 마이크로버블-나노입자 복합체 및 이를 포함하는 항암 치료제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4517762A (en) * 1983-07-08 1985-05-21 Venetz Louis M Animal trap holder
US4485806A (en) * 1983-10-24 1984-12-04 Calspan Corporation Method and apparatus for evacuating contaminated casualties
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4933121A (en) * 1986-12-10 1990-06-12 Ciba Corning Diagnostics Corp. Process for forming liposomes
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5422362A (en) * 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis

Also Published As

Publication number Publication date
EP0843547A1 (de) 1998-05-27
EP0843547B1 (de) 2002-10-23
DE69624485D1 (de) 2002-11-28
AU6608396A (en) 1997-02-26
DK0843547T3 (da) 2003-02-24
CA2227761A1 (en) 1997-02-13
ES2186792T3 (es) 2003-05-16
AU717181B2 (en) 2000-03-16
CA2227761C (en) 2004-01-06
DE69624485T2 (de) 2003-06-26
WO1997004746A1 (en) 1997-02-13
TW585785B (en) 2004-05-01
JP3782112B2 (ja) 2006-06-07
PT843547E (pt) 2003-03-31
US5707608A (en) 1998-01-13

Similar Documents

Publication Publication Date Title
DE69624485D1 (de) Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen
GB2331015A (en) Therapeutic methods and compositions involving isoflavones
DE58902737D1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
ES2157344T3 (es) Pirrolo(2,3-d)pirimidinas y su uso.
DE69614385D1 (de) Verfahren zur herstellung einer liposomen-zubereitung
ATE192924T1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
DE69519802D1 (de) Etherlipid-liposomen und deren therapeutische verwendung
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
TR199800608A2 (en) Propanolamin t�revleri, bunlar�n �retim usul�.
JPS6450812A (en) Hair dye composition and use
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
ATE233484T1 (de) Desinfizierende zusammensetzung
MX9601105A (es) Proceso para la preparacion de etil-n-(2,3-dicloro-6-nitrobencil)glicina.
ATE128466T1 (de) Verfahren zur herstellung von 2,7- diazabicyclo(3.3.0)octanen.
ATE3421T1 (de) 1-alkadien-2,4-yl-2-hydroxymethyl-3,4,5trihydroxy-piperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE50304242D1 (de) Verfahren zur herstellung von acylphosphinoxiden
DE69823064D1 (de) Verfahren zur herstellung von schwach gefärbten bis transparenten alkylglykosiden
DE69032153D1 (de) Verfahren zur Herstellung von Butantetracarboxylat
DE69333060D1 (de) Methoden zur herstellung praktisch reiner eg iii zellulase mittels alkohol
DE69323299D1 (de) Treibmittelzusammensetzung, herstellung von schaumstoff mittels dieser zusammensetzung und daraus hergestellte schaumstoffe
DE59914774D1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
BR9507135A (pt) Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética
DE69514512D1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE283909T1 (de) Verfahren zur herstellung von waschmittelgranulaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0843547

Country of ref document: EP